Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine (Q42266012)

19 October 2017

title

Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine (English)

1 reference

19 October 2017

6

Yhu-Chering Huang

1 reference

19 October 2017

Yu-Chia Hsieh

1

1 reference

19 October 2017

Fang-Tzy Wu

2

1 reference

19 October 2017

Chao A Hsiung

3

1 reference

19 October 2017

Ho-Sheng Wu

4

1 reference

19 October 2017

Kuang-Yi Chang

5

1 reference

19 October 2017

language of work or name

English

0 references

publication date

24 September 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

32

1 reference

19 October 2017

issue

10

1 reference

19 October 2017

page(s)

1199-1204

1 reference

Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Increased detection of rotavirus using a real time reverse transcription-polymerase chain reaction (RT-PCR) assay in stool specimens from children with diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Enhancement of detection and quantification of rotavirus in stool using a modified real-time RT-PCR assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

Rotavirus vaccines: viral shedding and risk of transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.041

10.1016/J.VACCINE.2013.08.041

7 January 2021

Identifiers

DOI

1 reference

release_wncbqr3pljbp3k3pufrm4zakta

19 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wncbqr3pljbp3k3pufrm4zakta

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference